<span style="font-family: Roboto; font-size: 12pt; vertical-align: baseline;">The nivolumab non-small cell lung cancer</span><span style="font-family: Roboto; font-size: 12pt; vertical-align: baseline;"> therapy starts after the binding of PD-1 receptors on the T-cells. This action helps the immune system to recognise and attack the cancer cells. It can help to decrease cancer cells and cancer spread throughout the body. On the other hand, consult with your doctor before taking this medicine.</span>